BA is pulling back from its August highs, down 4.4% on the week to $223.06, even as the analyst consensus remains firmly bullish — a divergence between what the Street says and what the price is doing.
Options traders are the most cautious they have been in months. The put/call ratio has climbed to 0.87, more than two standard deviations above its 20-day average of 0.85 — the highest z-score reading in the data window. That elevated demand for downside protection is notable because it has appeared just as the stock has given back its post-upgrade gains. The PCR 52-week range runs from 0.72 to 1.02, so the current reading is not extreme in absolute terms, but the speed of the move above the recent mean is the signal worth watching. Short interest, by contrast, tells a far less charged story: shares short are just 1.9% of the free float, up a modest 3.7% on the week. Borrow conditions remain essentially unconstraining — availability is at 9,700%, meaning there are roughly 97 shares available to lend for every one currently borrowed. Cost to borrow is 0.43%, barely changed. The lending market is not a source of stress here.
The Street remains strongly positioned for a recovery. Eighteen analysts carry Buy-equivalent ratings against just five Holds, and the mean price target implies roughly 19% upside from current levels. The most recent analyst actions were consistent with that tone — Argus upgraded to Buy on August 11 at a $265 target, and BNP Paribas made the boldest move earlier in August, flipping from Underperform to Outperform with a $300 target. JP Morgan lifted its Overweight target to $290 after the Q2 print. Factor scores corroborate the bullish read: EPS momentum ranks in the 90th and 98th percentiles on 30- and 90-day bases respectively, EPS surprise is in the 92nd percentile, and analyst recommendation divergence scores in the 99th. The valuation, however, gives bears a credible counter — the stock trades on a trailing P/E above 100 and EV/EBITDA near 31x, multiples that leave little room for execution stumbles. The bear case also points to production ramp risk and a still-stressed balance sheet.
Institutional flows add a constructive undertone. Capital Research and Management added nearly 10 million shares in the most recent reporting period, the largest incremental move among the top holders. BlackRock added close to 3 million shares. These are not token adjustments — they suggest active funds are building conviction at current levels, not trimming into the upgrade wave. The one insider trade worth noting is CEO Robert Ortberg selling 6,232 shares on August 10 for roughly $1.5 million, a transaction scored at the lowest significance tier, consistent with routine programme selling rather than a directional signal.
Boeing's most recent earnings print on July 28 produced a 1.2% gain on the day and a 12.1% gain over the following five sessions — a strong post-results tailwind that helped push the stock to its August highs. The next print is scheduled for October 21. The peer group is offering mixed signals this week: GE held up with a 1.9% weekly gain while EVEX fell 7% and CAE dropped 4.3%, suggesting sector-wide softness rather than Boeing-specific selling.
The October print is now the next meaningful catalyst, and the gap between the upgraded consensus targets and the stock's recent drift lower is the tension to monitor — whether options hedging at a two-standard-deviation extreme reflects temporary caution or something the fundamental data has not yet fully priced.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
